Zhejiang Xianju Pharmaceutical

Zhejiang Xianju Pharmaceutical is a company listed under the stock ticker 002332 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Zhejiang Xianju Pharmaceutical

• Yusong Zhang, Chairman of the Board and General Manager
• Weiwu Chen, Director
• Kanghua Chen, Director

Create your alert
to follow the executive moves at Zhejiang Xianju Pharmaceutical.

Zhejiang Xianju Pharmaceutical has 1,862 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Zhejiang Xianju Pharmaceutical

Social media about Zhejiang Xianju Pharmaceutical

• Zhejiang Xianju Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Zhejiang Xianju Pharmaceutical on LinkedIn, Twitter & YouTube

Call Zhejiang Xianju Pharmaceutical at +86 576 ...

View the org chart

Register to receive your alert

Report an error